Q3 net sales rose 0.2% year-over-year with strong EPS and cash flow growth. Sally segment outperformed with 3.5% comparable sales growth, while BSG declined. FY26 guidance narrowed, with continued focus on growth investments and shareholder returns.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.